Alexandra Cristina Senegaglia

Prof. Alexandra Cristina Senegaglia

Universidade Federal do Paraná - UFPR
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2008 in Experimental Biology and Medicine
Verified
Journal Article
Open access
CRC. K. Rebelatto
C. K. Rebelatto
AAA. M. Aguiar
A. M. Aguiar
MMM. P. Moretão
M. P. Moretão
ASAlexandra Cristina Senegaglia
Alexandra Cristina Senegaglia
PSPaula Hansen Suss
Paula Hansen Suss
ACA. Correa
A. Correa
Mesenchymal stem cells (MSCs) have been investigated as promising candidates for use in new cell-based therapeutic strategies such as mesenchyme-derived tissue repair. MSCs are easily isolated from adult tissues and are not ethically restricted. MSC-related literature, however, is conflicting in relation to MSC differentiation potential and molecular markers. Here we compared MSCs isolated from bone marrow (BM), umbilical cord blood (UCB), and adipose tissue (AT). The isolation efficiency for both BM and AT was 100%, but that from UCB was only 30%. MSCs from these tissues are morphologically and immunophenotypically similar although their differentiation diverges. Differentiation to osteoblasts and chondroblasts was similar among MSCs from all sources, as analyzed by cytochemistry. Adipogenic differentiation showed that UCB-derived MSCs produced few and small lipid vacuoles in contrast to those of BM-derived MSCs and AT-derived stem cells (ADSCs) (arbitrary differentiation values of 245.57 ± 943 and 243.89 ± 145.52 μm2 per nucleus, respectively). The mean area occupied by individual lipid droplets was 7.37 μm2 for BM-derived MSCs and 2.36 μm2 for ADSCs, a finding indicating more mature adipocytes in BM-derived MSCs than in treated cultures of ADSCs. We analyzed FAPB4, ALP, and type II collagen gene expression by quantitative polymerase chain reaction to confirm adipogenic, osteogenic, and chondrogenic differentiation, respectively. Results showed that all three sources presented a similar capacity for chondrogenic and osteogenic differentiation and they differed in their adipogenic potential. Therefore, it may be crucial to predetermine the most appropriate MSC source for future clinical applications.

4 January 2017 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
AAAddeli B. B. Angulski
Addeli B. B. Angulski
LCLuiz G. Capriglione
Luiz G. Capriglione
MBMichel Batista
Michel Batista
BMBruna Hilzendeger Marcon
Bruna Hilzendeger Marcon
ASAlexandra Cristina Senegaglia
Alexandra Cristina Senegaglia
ACAlejandro Correa
Alejandro Correa

4 July 2006 in Circulation
Verified
Journal Article
Closed access
PDF file
LGL.C. Guarita-Souza
L.C. Guarita-Souza
KCKatherine Athayde Teixeira de Carvalho
Katherine Athayde Teixeira de Carvalho
VWV. Woitowicz
V. Woitowicz
CRC. Rebelatto
C. Rebelatto
ASAlexandra Cristina Senegaglia
Alexandra Cristina Senegaglia
PBP. Brofman
P. Brofman
Background— Cellular transplantation is emerging as a promising strategy for the treatment of postinfarction ventricular dysfunction. Whether its beneficial effects can be extended to other cardiomyopathies remains an unexplored question. We evaluated the histological and functional effects of simultaneous autologous transplantation of co-cultured stem cells and skeletal myoblasts in an experimental model of dilated cardiomyopathy caused by Chagas disease, characterized by diffuse fibrosis and impairment of microcirculation. Methods and Results— Wistar rats weighing 200 grams were infected intraperitoneally with 15×10 4 trypomastigotes. After 8 months, 2-dimensional echocardiographic study was performed for baseline assessment of left ventricle (LV) ejection fraction (EF) (%), left ventricle end-diastolic volume (LVEDV) (mL), and left ventricle end-systolic volume (LVESV) (mL). Animals with LV dysfunction (EF 90%. Eleven animals received autologous transplant of 5.4×10 6 ±8.0×10 6 cells (300 μL) into the LV wall. The control group (n=10) received culture medium (300 μL). Cell types were identified with vimentin and fast myosin. After 4 weeks, ventricular function was reassessed by echo. For histological analysis, heart tissue was stained with hematoxylin and eosin and immunostained for fast myosin. After 4 weeks, cell transplantation significantly improved EF and reduced LVEDV and LVESV. No change was observed in the control group. Conclusion— The co-transplant of stem cells and skeletal myoblasts is functionally effective in the Chagas disease ventricular dysfunction.

11 February 2019 in Stem Cells International
Verified
Journal Article
Open access
PDF file
CFClaudio Luciano Franck
Claudio Luciano Franck
ASAlexandra Cristina Senegaglia
Alexandra Cristina Senegaglia
LLLidiane Maria Boldrini Leite
Lidiane Maria Boldrini Leite
SMSérgio Adriane Bezerra de Moura
Sérgio Adriane Bezerra de Moura
NFNathália Forti Francisco
Nathália Forti Francisco
JFJurandir Marcondes Ribas Filho
Jurandir Marcondes Ribas Filho
Burns are lesions in which the thermal energy of the causative agent transfers heat to the surface of the body, causing superficial or deep damage to the skin with protein denaturation in cells and biochemical maladjustments, which delay and disrupt the cicatricial process, increasing the chances of functional and aesthetic sequelae. This study evaluates the influence of adipose tissue-derived stem cells (ADSCs) on burn healing in terms of the size of the cicatricial space and quantified measures of collagen deposition, inflammatory infiltrate, blood vessels, and lymphatic vessels. Initially, intra-abdominal adipose tissue was resected from a single donor Wistar rat that was not part of any of the subsequent groups to obtain ADSCs by isolation and cell culture. Burns were made in the left lateral abdominal region of Wistar rats by contact with a square ceramic paper with a 484 mm2 area heated to 100°C for 30 seconds. Intradermal ADSC transplantation was performed in two stages. The first was on the same day of the burn, when 3.2×106 ADSCs were transplanted shortly after the burned region cooled, while the second stage occurred four days later with the same number of ADSCs. The progress was evaluated by immunohistochemical methods and H&E, Masson’s trichrome, Picrosirius red, and Lyve-1 immunofluorescence staining. Despite the quantitative similarity of blood vessels and the inflammatory infiltrate observed by H&E, there were statistically significant differences between the groups on the fourteenth day of evolution. The group that received ADSCs showed a reduction in the scar tissue area, increased collagen type III deposition, and a quantifiable reduction in lymphatic vessels, so we conclude that ADSCs influence the healing of total thickness burns in rats.

2 June 2020 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
DADebora B. Araujo
Debora B. Araujo
JDJoana R. Dantas
Joana R. Dantas
KSKarina R. Silva
Karina R. Silva
DSDébora Souto
Débora Souto
MPMaria de Fátima C. Pereira
Maria de Fátima C. Pereira
MRMelanie Rodacki
Melanie Rodacki
Objective: To evaluate the short term safety and potential therapeutic effect of allogenic adipose tissue-derived stromal/stem cells (ASCs) + cholecalciferol in patients with recent-onset T1D. Methods: Prospective, phase II, open trial, pilot study in which patients with recent onset T1D received ASCs (1 × 106 cells/kg) and cholecalciferol 2000 UI/day for 3 months (group 1) and were compared to controls with standard insulin therapy (group 2). Adverse events, C-peptide (CP), insulin dose, HbA1c, time in range (TIR), glucose variability (continuous glucose monitoring) and frequency of CD4+FoxP3+ T-cells (flow cytometry) were evaluated at baseline (T0) and after 3 months (T3). Results: 13 patients were included (8: group 1; 5: group 2). Their mean age and disease duration were 26.7 ± 6.1 years and 2.9 ± 1.05 months. Adverse events were transient headache (n = 8), mild local reactions (n = 7), tachycardia (n = 4), abdominal cramps (n = 1), thrombophlebitis (n = 4), mild floaters (n = 2), central retinal vein occlusion (n = 1, complete resolution). At T3, group 1 had lower insulin requirement (0.22 ± 0.17 vs. 0.61±0.26IU/Kg; p = 0.01) and HbA1c (6.47 ± 0.86 vs. 7.48 ± 0.52%; p = 0.03) than group 2. In group 1, 2 patients became insulin free (for 4 and 8 weeks) and all were in honeymoon at T3 (vs. none in group 2; p = 0.01). CP variations did not differ between groups (−4.6 ± 29.1% vs. +2.3 ± 59.65%; p = 0.83). Conclusions: Allogenic ASCs + cholecalciferol without immunosuppression was associated with stability of CP and unanticipated mild transient adverse events in patients with recent onset T1D. ClinicalTrials.gov registration: NCT03920397.

1 May 2014 in Revista Brasileira de Ginecologia e Obstetrícia
Verified
Journal Article
Open access
TBTamara Borgonovo
Tamara Borgonovo
IVIsadora May Vaz
Isadora May Vaz
ASAlexandra Cristina Senegaglia
Alexandra Cristina Senegaglia
CRCarmen Lucia Kuniyoshi Rebelatto
Carmen Lucia Kuniyoshi Rebelatto
PBPaulo Roberto Slud Brofman
Paulo Roberto Slud Brofman
To present the initial results of first three years of implementation of a genetic evaluation test for bone marrow-derived mesenchymal stem cells in a Cell Technology Center. A retrospective study was carried out of 21 candidates for cell therapy. After the isolation of bone marrow mononuclear cells by density gradient, mesenchymal stem cells were cultivated and expanded at least until the second passage. Cytogenetic analyses were performed before and after cell expansion (62 samples) using G-banded karyotyping. All the samples analyzed, before and after cell expansion, had normal karyotypes, showing no clonal chromosomal changes. Signs of chromosomal instability were observed in 11 out of 21 patients (52%). From a total of 910 analyzed metaphases, five chromatid gaps, six chromatid breaks and 14 tetraploid cells were detected giving as total of 25 metaphases with chromosome damage (2.75%). The absence of clonal chromosomal aberrations in our results for G-banded karyotyping shows the maintenance of chromosomal stability of bone marrow-derived mesenchymal stem cells until the second passage; however, signs of chromosomal instability such as chromatid gaps, chromosome breaks and tetraploidy indicate that the long-term cultivation of these cells can provide an intermediate step for tumorigenesis.